vision loss with tirzepatide Mounjaro Eye Side Effects Lawsuit [2026 Update] While GLP-1 drugs have been
Description
7 The illness, primarily affecting obese women of reproductive age, causes severe symptoms such as recurrent headaches and papilledema, potentially causing irreversible vision impairment if ignored
The frequency increases with higher doses, ranging from approximately 14% at the 5 mg dose to 25% at the 10 mg dose and 32% at the 15 mg maintenance dose
![vision loss with tirzepatide Mounjaro Eye Side Effects Lawsuit [2026 Update] While GLP-1 drugs have been](https://cdn.sanity.io/images/0vv8moc6/ajmc/1e72c17056849745102fb2a66d19c20ae16bafaf-1200x724.jpg)
a hoarse voice
![vision loss with tirzepatide Mounjaro Eye Side Effects Lawsuit [2026 Update] While GLP-1 drugs have been](https://classactionlawyertn.com/wp-content/uploads/2025/11/zepbound-and-vision-loss-feature-image.webp)
What do the new studies say
![vision loss with tirzepatide Mounjaro Eye Side Effects Lawsuit [2026 Update] While GLP-1 drugs have been](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2025/06/woman-holding-semaglutide-1296x728-header-1024x575.jpg)